Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008.

scientific article published on 4 February 2011

Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/S146114571000163X
P698PubMed publication ID21294941

P50authorGabor S UngvariQ89771723
Ross J. BaldessariniQ91160298
Chay Hoon TanQ93036612
Naotaka ShinfukuQ93036615
Chee Kok YoonQ98153922
Yu-Tao XiangQ105682989
Mian-Yoon ChongQ114439012
Pichet UdomratnQ114439013
Senta FujiiQ114439033
Eun-Kee ChungQ114439035
Kian Hui YongQ114439049
Chuan-Yue WangQ38317792
P2093author name stringTze Pin Ng
Tianmei Si
Norman Sartorius
Kang Sim
Shu-Yu Yang
Edwin Ho Ming Lee
Ee Heok Kua
Yan Ling He
Phern-Chern Tor
Jintendra Trivedi
P2860cites workPredictors of benzodiazepine discontinuation in subjects manifesting complicated dependenceQ28245171
The diagnosis and management of benzodiazepine dependenceQ33995356
National trends in psychotropic medication polypharmacy in office-based psychiatryQ34090959
Guidelines for the rational use of benzodiazepines. When and what to use.Q34292715
A national study of violent behavior in persons with schizophreniaQ34519980
Psychotropic drugs and the ECG: focus on the QTc intervalQ34628573
Valproate as an adjunct to antipsychotics for schizophrenia: a systematic review of randomized trials.Q35832661
Is schizoaffective disorder a stable diagnostic category: a retrospective examinationQ35873634
The epidemiology of long-term benzodiazepine use.Q36272510
Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamicsQ36597641
Sedative-hypnotic treatment in an acute psychiatric setting: comparison with best practice guidanceQ36749503
[Benzodiazepines and schizophrenia, a review of the literature]Q79987379
Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmaciesQ80777599
Patterns of clinical use of antipsychotics in hospitalized psychiatric patientsQ80952998
Diagnostic stability 2 years after treatment initiation in the early psychosis intervention programme in SingaporeQ36824780
Long-term benzodiazepine use: factors of importance and the development of individual use patterns over time--a 13-year follow-up in a Swedish communityQ36867003
McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patientsQ37268306
Psychotropic prescription practices in east Asia: looking back and peering aheadQ37293066
Pharmacotherapy for schizophrenic inpatients in East Asia--changes and challengesQ37326610
Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence?Q37356492
Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based studyQ38450245
Benzodiazepines--a necessary evil? A survey of prescribing at a specialist UK psychiatric hospitalQ39343783
The treatment of benzodiazepine dependenceQ40583044
Initial 3-month usage characteristics predict long-term use of benzodiazepines: an 8-year follow-upQ40603054
Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophreniaQ40748688
Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepinesQ41880908
International consensus study of antipsychotic dosing.Q43111655
A case of torsades de pointes induced by severe QT prolongation after an overdose of eperisone and triazolam in a patient receiving nifedipineQ43144173
Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004.Q43145170
Does the sedative agent, JM-1232(-) cause QT prolongation with subsequent torsades de pointes?Q43260722
Benzodiazepine use among depressed patients treated in mental health settingsQ43754846
Clinical and social determinants of psychotropic drug prescription for schizophrenia outpatients in ChinaQ43903295
Predictors of relapse after discontinuation of long-term benzodiazepine use by minimal intervention: a 2-year follow-up studyQ44522419
Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disordersQ44616581
Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change.Q44695401
Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.Q44787812
Lorazepam-induced prolongation of the QT interval in a patient with schizoaffective disorder and complete AV blockQ44999952
Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance programQ45241753
Characterizations of long-term anxiolytic benzodiazepine prescriptions in veteran patientsQ45332949
Re: Lorazepam-induced prolongation of the QT interval in a patient with schizoaffective disorder and complete AV blockQ46438046
Stability of diagnosis in bipolar disorderQ46463784
Predictors of discontinuation of benzodiazepine prescription after sending a letter to long-term benzodiazepine users in family practice.Q46656351
Clinical and social determinants of long-term use of benzodiazepines and its impact on quality of life of Chinese schizophrenia patients.Q46887847
Prescribing for inpatients with schizophrenia: an international multi-center comparative studyQ47707078
Are patterns of benzodiazepine use predictable? A follow-up study of benzodiazepine usersQ48880087
Patterns of benzodiazepine use in Great Britain as measured by a general population surveyQ48934176
Violence among schizophrenia out-patients compliant with medication: prevalence and associated factors.Q50620270
Prescription of benzodiazepines and antidepressants to outpatients attending a Japanese university hospital.Q50797162
Regular prescriptions for benzodiazepines: a cross-sectional study of outpatients at a university hospital.Q51773522
High dose diazepam treatment and its effect on prolactin secretion in adolescent schizophrenic patients.Q51849598
Nature and frequency of aggressive behaviours among long-term inpatients with schizophrenia: a 6-month report using the modified overt aggression scale.Q51887777
High dose antipsychotic use in schizophrenia: findings of the REAP (research on east Asia psychotropic prescriptions) study.Q51936776
Prescription of psychotropic drugs to patients with schizophrenia: an Italian national survey.Q51938230
Pharmacoepidemiology of psychotropic drugs in patients with severe mental disorders in Italy. Italian Collaborative Study Group on the Outcome of Severe Mental Disorders.Q51978180
Benzodiazepine prescribing patterns in a high-prescribing Scandinavian community.Q52039881
Chlorpromazine Equivalent Doses for the Newer Atypical AntipsychoticsQ55969829
Guidelines for depot antipsychotic treatment in schizophreniaQ58231296
Predictors of chronic benzodiazepine use in a health maintenance organization sampleQ71466464
Comparative study on benzodiazepine use in Canada and ChileQ72211854
P433issue6
P921main subjectschizophreniaQ41112
hospitalizationQ3140971
P304page(s)735-745
P577publication date2011-02-04
P1433published inThe International Journal of NeuropsychopharmacologyQ7742309
P1476titleAdjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008.
P478volume14

Reverse relations

cites work (P2860)
Q36021004An audit of first prescription of new patients attending a psychiatry walk-in-clinic in north India
Q41682303Antipsychotic polypharmacy among elderly patients with schizophrenia and dementia during hospitalization at a Taiwanese psychiatric hospital
Q44897335Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China
Q36324947Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set.
Q47796515Common use of anticholinergic medications in older patients with schizophrenia: findings of the Research on Asian Psychotropic Prescription Pattern (REAP) study, 2001-2009.
Q38950803Comparison of treatment patterns in schizophrenia between China and Japan (2001-2009).
Q44024907Long-term benzodiazepine use in patients with major depressive disorder in China
Q40520509Prevalence of Insomnia and Clinical and Quality of Life Correlates in Chinese Patients With Schizophrenia Treated in Primary Care
Q64779712Psychotropic drug-prescribing correlates of disorganized speech in Asians with schizophrenia: The REAP-AP study
Q50579730Should benzodiazepines still have a role in treating patients with anxiety disorders?
Q40626667Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia

Search more.